×
RIVAL Study – Novartis

RIVAL Study – Novartis

Development of new geographic atrophy in patients with neovascular (wet) age-related macular degeneration: A comparison of ranibizumab and aflibercept.

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment